-
Symbol
-
TRDA on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
2.57M shares
-
Security Ownership
-
6.9%
Roche Finance Ltd ownership in Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share (TRDA)
2025-02-14 - Roche Finance Ltd has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.57M shares of Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share (TRDA).
This represents 6.9% percent ownership of the company.